CUBE Study COVID-19 Survey

This study was conducted in KwaZulu-Natal province, South Africa and Lusaka, Zambia with female contraceptive users from the longitudinal Contraceptive Use Beyond ECHO (CUBE) study. The COVID-19 module of the CUBE study was a descriptive, cross-sectional design with the following data components: -Phone survey with CUBE participants (n=537) -In-depth interviews (IDIs) with a subset of CUBE participants (n=39) -IDIs with key informants, including health care providers, Ministry of Health officials/program managers, and community advocates (n=36) Data from IDIs are not included in this dataverse. This work was made possible through the generous support of the American people through the United States Agency for International Development (USAID), provided to FHI 360 through Cooperative Agreement AID-OAA-A-15-00045 and Cooperative Agreement 7200AA19CA00041. The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study was made possible by the combined generous support of the Bill & Melinda Gates Foundation (Grant OPP1032115), the American people through the United States Agency for International Development (Grant AID-OAA-A-15–00045), the Swedish International Development Cooperation Agency (Grant 2017/762965–0), the South Africa Medical Research Council, and the United Nations Population Fund. Partners on this work include MRU (MatCH Research Unit), Department of Obstetrics and Gynecology, Faculty of Health Sciences, University of the Witwatersrand, Division of Global Women’s Health, Department of Obstetrics and Gynecology, University of North Carolina (UNC) at Chapel Hill, and UNC Global Projects.